Know Cancer

or
forgot password

Evaluation the Feasibility of the FOSTI Device Accurately and in a Real Time Way to Differentiate Malignant From Benign Tissue (Performed ex Vivo) in Cancer Surgery


N/A
N/A
N/A
Open (Enrolling)
Both
Cancer

Thank you

Trial Information

Evaluation the Feasibility of the FOSTI Device Accurately and in a Real Time Way to Differentiate Malignant From Benign Tissue (Performed ex Vivo) in Cancer Surgery


Characterization of the optical fiber sensor's interaction with the tissue.

Creating a database of tissue lesions and their 'optical signature' (lesion classifier).

Optimization of the FOSTI device by minimizing the false-positive and false-negative
results.


Inclusion Criteria:



- Subjects of all ages.

- Subject is able, agree and sign the Informed Consent Form.

Exclusion Criteria:

- Subject has any conditions, which precludes compliance with study

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Principal Investigator

Anatoliy Babchenko

Investigator Role:

Study Director

Investigator Affiliation:

Optivasive Ltd.

Authority:

Israel: Ethics Commission

Study ID:

OpVe-HI-08-001

NCT ID:

NCT00791609

Start Date:

March 2008

Completion Date:

Related Keywords:

  • Cancer
  • cancer

Name

Location